Our objective was to determine whether ACSS2 mediates the loss of synaptic plasticity in the AD brain and whether supplementation of ACSS2 substrate (acetate) can enhance synaptic plasticity and improve cognition. The gene discussed is ACSS2; the disease is Alzheimer disease.